Skip to main content
Caplight Logo









Orio Therapeutics SA

Orio Therapeutics SA

Private
MontheyHealthcare & Life Scienceshttps://oriotx.com/

Last Round

Grant

Jun 3, 2024

Total Funding Raised

$720,000

Company Overview

Orio Therapeutics SA is a biotechnology company developing regenerative drugs using protein engineering and targeted drug-delivery technologies, with an initial focus on a cardioprotective therapy for heart attack patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

protein engineeringdrug delivery platformregenerative medicinecardioprotective drugregen medtargeted drug deliverymyocardial infarction therapybiologics developmenttherapeutic proteinspre-clinical biotechdrug licensingdrug co-development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orio Therapeutics SA Comparables

Compare Orio Therapeutics SA with similar companies based on industry and business-model similarity.

Orio Therapeutics SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Regencor
79%
TargaCell Corporation
76%
AI Proteins
63%

Orio Therapeutics SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 3, 2024
Pre SeedApr 4, 2024

Key People

Founding team and executive leadership

Ziad Julier

Co-founder And CEO

Founding Team

Orio Therapeutics SA Investors

Notable investors and investment history

Orio Therapeutics SA investors
InvestorRounds
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 74% MoM, reaching 3.2K.

  • May 2, 2025

    Monthly visitors increased 156% MoM, reaching 1.7K.

Orio Therapeutics SA Filings

Explore SEC and related filing metadata, where available.

Orio Therapeutics SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Orio Therapeutics SA's valuation, stock price, and market status.

Is Orio Therapeutics SA a public or private company?

Orio Therapeutics SA is a private company.

What is the current stock price of Orio Therapeutics SA?

Orio Therapeutics SA is a private company with no public stock price. No recent secondary market data is available.

How much is Orio Therapeutics SA worth (valuation)?

Valuation information for Orio Therapeutics SA is not publicly available.

Can I buy Orio Therapeutics SA stock?

Orio Therapeutics SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Orio Therapeutics SA's last funding round?

Orio Therapeutics SA's most recent funding round was Grant on June 3, 2024.

Who are the main investors in Orio Therapeutics SA?

Key investors in Orio Therapeutics SA include Venture Kick.

Will Orio Therapeutics SA IPO soon?

No public IPO plans have been announced for Orio Therapeutics SA.

How can I track Orio Therapeutics SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orio Therapeutics SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMonthey
Employee Range2
Year Founded2023
Last FundingJun 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?